CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Jazz Pharmaceuticals plc - JAZZ CFD

    127.31
    0.55%
    0.70
    Rendah: 127.31
    Tinggi: 129.56
    Market Trading Hours* (UTC) Opens on Friday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.70
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Jazz Pharmaceuticals PLC ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    Key Stats
    Prev. Close* 128.02
    Open* 127.38
    1-Year Change* -17.45%
    Day's Range* 127.31 - 129.56
    52 wk Range 125.35-163.31
    Average Volume (10 days) 717.39K
    Average Volume (3 months) 10.39M
    Market Cap 8.23B
    P/E Ratio -100.00K
    Shares Outstanding 64.00M
    Revenue 3.74B
    EPS -2.64
    Dividend (Yield %) N/A
    Beta 0.74
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 8, 2023 127.31 -0.57 -0.45% 127.88 129.56 126.65
    Jun 7, 2023 128.02 0.09 0.07% 127.93 128.87 126.40
    Jun 6, 2023 128.41 -0.64 -0.50% 129.05 130.33 127.88
    Jun 5, 2023 129.12 3.44 2.74% 125.68 129.82 125.09
    Jun 2, 2023 127.79 -0.16 -0.13% 127.95 130.21 127.35
    Jun 1, 2023 128.50 1.59 1.25% 126.91 129.06 125.39
    May 31, 2023 128.14 2.33 1.85% 125.81 129.74 125.40
    May 30, 2023 126.37 1.31 1.05% 125.06 127.34 124.96
    May 26, 2023 125.65 -0.29 -0.23% 125.94 127.39 125.14
    May 25, 2023 127.07 0.37 0.29% 126.70 127.76 125.09
    May 24, 2023 128.72 -0.01 -0.01% 128.73 130.55 128.00
    May 23, 2023 129.79 -2.14 -1.62% 131.93 133.66 129.67
    May 22, 2023 132.67 -0.98 -0.73% 133.65 135.07 132.05
    May 19, 2023 133.80 2.49 1.90% 131.31 134.79 131.31
    May 18, 2023 131.61 1.93 1.49% 129.68 131.85 129.26
    May 17, 2023 131.54 1.66 1.28% 129.88 132.16 129.30
    May 16, 2023 130.93 -2.76 -2.06% 133.69 133.69 130.22
    May 15, 2023 134.13 0.46 0.34% 133.67 136.39 133.43
    May 12, 2023 135.15 -1.25 -0.92% 136.40 137.26 133.46
    May 11, 2023 136.57 0.14 0.10% 136.43 140.47 135.79

    Jazz Pharmaceuticals plc Events

    Time (UTC) Country Event
    Tuesday, June 13, 2023

    Time (UTC)

    22:20

    Country

    IE

    Event

    Jazz Pharmaceuticals PLC at Goldman Sachs Healthcare Conference
    Jazz Pharmaceuticals PLC at Goldman Sachs Healthcare Conference

    Forecast

    -

    Previous

    -
    Friday, July 28, 2023

    Time (UTC)

    08:45

    Country

    IE

    Event

    Jazz Pharmaceuticals PLC Annual Shareholders Meeting
    Jazz Pharmaceuticals PLC Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 3659.37 3094.24 2363.57 2161.76 1890.92
    Revenue 3659.37 3094.24 2363.57 2161.76 1890.92
    Cost of Revenue, Total 540.517 440.76 148.917 127.93 121.544
    Gross Profit 3118.86 2653.48 2214.65 2033.83 1769.38
    Total Operating Expense 3724.9 2923.96 1990.59 1629.39 1277.51
    Selling/General/Admin. Expenses, Total 1376.17 1222.68 854.233 736.942 683.53
    Research & Development 1034.6 505.748 586.625 409.701 226.616
    Depreciation / Amortization 599.169 525.769 259.58 354.814 201.498
    Unusual Expense (Income) 174.448 229 141.239 0 44.321
    Operating Income -65.528 170.278 372.973 532.374 613.413
    Interest Income (Expense), Net Non-Operating -307.256 -283.116 -97.878 -78.072 -86.153
    Net Income Before Taxes -372.784 -112.838 275.095 454.302 527.26
    Net Income After Taxes -214.139 -328.954 241.578 527.456 447.091
    Minority Interest
    Net Income Before Extra. Items -224.06 -329.668 238.616 523.367 447.091
    Net Income -224.06 -329.668 238.616 523.367 447.098
    Income Available to Common Excl. Extra. Items -224.06 -329.668 238.616 523.367 447.091
    Income Available to Common Incl. Extra. Items -224.06 -329.668 238.616 523.367 447.098
    Dilution Adjustment 0
    Diluted Net Income -224.06 -329.668 238.616 523.367 447.098
    Diluted Weighted Average Shares 62.539 59.694 56.517 57.55 61.221
    Diluted EPS Excluding Extraordinary Items -3.58272 -5.52263 4.22202 9.09413 7.30289
    Diluted Normalized EPS -1.7696 -3.02908 6.4166 9.09413 7.91677
    Total Extraordinary Items 0 0.0075
    Equity In Affiliates -9.921 -0.714 -2.962 -4.089
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 892.812 972.123 940.652 932.878 813.721
    Revenue 892.812 972.123 940.652 932.878 813.721
    Cost of Revenue, Total 128.644 167.364 133.661 124.208 115.284
    Gross Profit 764.168 804.759 806.991 808.67 698.437
    Total Operating Expense 766.757 1235.51 915.889 847.332 726.172
    Selling/General/Admin. Expenses, Total 297.917 383.203 317.678 325.673 308.813
    Research & Development 190.41 547.555 148.87 208.195 129.981
    Depreciation / Amortization 149.786 137.387 141.232 148.456 172.094
    Unusual Expense (Income) 0 174.448 40.8
    Operating Income 126.055 -263.386 24.763 85.546 87.549
    Interest Income (Expense), Net Non-Operating -70.954 -76.607 -84.893 -64.532 -81.224
    Net Income Before Taxes 55.101 -339.993 -60.13 21.014 6.325
    Net Income After Taxes 70.425 -239.951 -17.103 37.126 5.789
    Equity In Affiliates -1.005 -0.773 -2.545 -2.461 -4.142
    Net Income Before Extra. Items 69.42 -240.724 -19.648 34.665 1.647
    Net Income 69.42 -240.724 -19.648 34.665 1.647
    Income Available to Common Excl. Extra. Items 69.42 -240.724 -19.648 34.665 1.647
    Income Available to Common Incl. Extra. Items 69.42 -240.724 -19.648 34.665 1.647
    Diluted Net Income 69.42 -240.724 -19.648 34.665 1.647
    Diluted Weighted Average Shares 73.771 63.061 62.785 63.431 62.907
    Diluted EPS Excluding Extraordinary Items 0.94102 -3.81732 -0.31294 0.5465 0.02618
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.94102 -3.81732 1.49308 0.96459 0.02618
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 2606.14 2611.33 2839.57 1630.27 1234.01
    Cash and Short Term Investments 881.482 591.448 2132.77 1077.34 824.622
    Cash & Equivalents 517.464
    Short Term Investments 30 80.701 1615.65 744.172 609.016
    Total Receivables, Net 742.628 563.36 396.49 355.987 263.838
    Accounts Receivable - Trade, Net 651.493 563.36 396.49 355.987 263.838
    Total Inventory 714.061 1072.72 95.396 78.608 52.956
    Prepaid Expenses 91.912 131.413 62.422 39.434 25.017
    Other Current Assets, Total 176.057 252.392 152.491 78.895 67.572
    Total Assets 10835.3 12298.6 6535.9 5538.9 5203.49
    Property/Plant/Equipment, Total - Net 301.376 343.423 257.104 270.891 200.358
    Property/Plant/Equipment, Total - Gross 409.023 428.794 324.692 326.148 249.966
    Accumulated Depreciation, Total -107.647 -85.371 -67.588 -55.257 -49.608
    Goodwill, Net 1692.66 1827.61 958.303 920.018 927.63
    Intangibles, Net 5794.44 7152.33 2195.05 2440.98 2731.33
    Other Long Term Assets, Total 440.64 363.945 285.875 276.743 110.164
    Total Current Liabilities 933.193 809.303 653.745 364.49 345.487
    Accounts Payable 90.758 100.298 26.945 47.545 40.602
    Accrued Expenses 802.874 647.479 349.107 266.836 263.427
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 31.381 31.406 246.322 33.387 33.387
    Other Current Liabilities, Total 8.18 30.12 31.371 16.722 8.071
    Total Liabilities 7749.52 8333.45 2876.16 2427.92 2446.07
    Total Long Term Debt 5698.55 6025.21 1848.52 1573.87 1563.03
    Long Term Debt 5693.34 6018.94 1848.52 1573.87 1563.03
    Deferred Income Tax 944.337 1300.54 130.397 224.095 309.097
    Other Liabilities, Total 173.44 198.392 243.498 265.461 228.46
    Total Equity 3085.73 3965.19 3659.75 3110.98 2757.42
    Common Stock 0.061 0.061 0.061 0.061 0.061
    Additional Paid-In Capital 3477.12 3534.79 2633.67 2266.03 2113.63
    Retained Earnings (Accumulated Deficit) 734.058 830.698 1160.37 1068.29 841.522
    Other Equity, Total -1125.51 -400.36 -134.352 -223.393 -197.791
    Total Liabilities & Shareholders’ Equity 10835.3 12298.6 6535.9 5538.9 5203.49
    Total Common Shares Outstanding 63.214 61.633 56.171 56.14 57.504
    Cash 334.018 510.747 517.117 333.172 215.606
    Capital Lease Obligations 5.21 6.269
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 2784.65 2606.14 2571.5 2590.83 2500.86
    Cash and Short Term Investments 1167.91 881.482 899.358 771.265 490.835
    Cash 424.139 334.018 296.686 380.328 410.125
    Cash & Equivalents 563.772 517.464 542.672 290.937
    Short Term Investments 180 30 60 100 80.71
    Total Receivables, Net 681.154 651.493 601.179 594.034 572.392
    Accounts Receivable - Trade, Net 623.938 651.493 601.179 594.034 572.392
    Total Inventory 674.778 714.061 728.074 861.705 985.454
    Prepaid Expenses 72.779 91.912 92.877 108.304 117.399
    Other Current Assets, Total 188.028 267.192 250.016 255.525 334.776
    Total Assets 11047.1 10835.3 10384.7 11200.1 11768.9
    Property/Plant/Equipment, Total - Net 303.09 301.376 290.067 317.888 341.044
    Property/Plant/Equipment, Total - Gross 419.23 409.023 388.038 414.57 433.74
    Accumulated Depreciation, Total -116.14 -107.647 -97.971 -96.682 -92.696
    Goodwill, Net 1723.44 1692.66 1592.64 1687.65 1782.44
    Intangibles, Net 5764.21 5794.44 5570.39 6237.96 6783.06
    Other Long Term Assets, Total 471.732 440.64 360.067 365.805 361.516
    Total Current Liabilities 908.902 933.193 812.954 705.442 737.409
    Accounts Payable 125.454 90.758 102.249 74.161 73.336
    Accrued Expenses 711.779 803.255 630.648 569.174 596.292
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 31 31 31 31 31
    Other Current Liabilities, Total 40.669 8.18 49.057 31.107 36.781
    Total Liabilities 7712.08 7749.52 7639.47 7999.35 8160.43
    Total Long Term Debt 5689.66 5693.34 5695.81 5990 5992.87
    Long Term Debt 5689.66 5693.34 5695.81 5990 5992.87
    Deferred Income Tax 932.247 944.337 933.67 1096.42 1222.08
    Other Liabilities, Total 181.273 178.65 197.035 207.496 208.069
    Total Equity 3335.04 3085.73 2745.19 3200.78 3608.49
    Common Stock 0.061 0.061 0.061 0.061 0.061
    Additional Paid-In Capital 3511.73 3477.12 3388 3312.32 3239.33
    Retained Earnings (Accumulated Deficit) 803.478 734.058 974.782 994.43 959.819
    Other Equity, Total -980.23 -1125.51 -1617.65 -1106.03 -590.72
    Total Liabilities & Shareholders’ Equity 11047.1 10835.3 10384.7 11200.1 11768.9
    Total Common Shares Outstanding 63.987 63.214 62.89 62.623 62.244
    Capital Lease Obligations
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -224.06 -329.668 238.616 523.367 447.098
    Cash From Operating Activities 1271.98 778.507 899.648 776.401 798.904
    Cash From Operating Activities 30.302 26.714 18.673 15.342 15.233
    Amortization 599.169 525.769 259.58 354.814 201.498
    Deferred Taxes -292.251 69.198 -136.937 -236.61 -88.815
    Non-Cash Items 875.52 311.361 605.153 269.572 200.604
    Cash Taxes Paid 94.681 271.217 226.823 183.61 164.217
    Cash Interest Paid 270.671 138.271 42.47 43.002 42.706
    Changes in Working Capital 283.297 175.133 -85.437 -150.084 23.286
    Cash From Investing Activities -446.23 -5212.14 -1007.67 -155.3 -394.487
    Capital Expenditures -498.194 -45.532 -379.254 -182.335 -131.47
    Other Investing Cash Flow Items, Total 51.964 -5166.61 -628.416 27.035 -263.017
    Cash From Financing Activities -529.491 3970.52 528.073 -293.745 -479.13
    Financing Cash Flow Items -45.443 -35.602 -16.877 -16.739 -23.078
    Issuance (Retirement) of Stock, Net 97.966 135.261 -46.856 -243.619 -430.335
    Issuance (Retirement) of Debt, Net -582.014 3870.86 591.806 -33.387 -25.717
    Foreign Exchange Effects -6.222 -3.207 0.374 0.366 -1.7
    Net Change in Cash 290.034 -466.321 420.425 327.722 -76.413
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 69.42 -224.06 16.664 36.312 1.647
    Cash From Operating Activities 320.708 1271.98 930.006 512.015 208.979
    Cash From Operating Activities 7.574 30.302 22.958 15.364 7.617
    Amortization 149.786 599.169 461.782 320.55 172.094
    Deferred Taxes -66.061 -292.251 -146.874 -82.315 -45.339
    Non-Cash Items 81.207 875.52 421.208 208.514 49.707
    Changes in Working Capital 78.782 283.297 154.268 13.59 23.253
    Cash From Investing Activities -4.822 -446.23 -121.852 -126.454 -37.292
    Capital Expenditures -4.822 -498.194 -113.816 -118.718 -37.292
    Other Investing Cash Flow Items, Total 51.964 -8.036 -7.736 0
    Cash From Financing Activities -29.788 -529.491 -549.087 -260.034 -270.811
    Financing Cash Flow Items -43.266 -45.443 -42.632 -40.065 -33.776
    Issuance (Retirement) of Stock, Net 21.228 97.966 67.809 46.549 21.729
    Issuance (Retirement) of Debt, Net -7.75 -582.014 -574.264 -266.518 -258.764
    Foreign Exchange Effects 0.331 -6.222 -11.157 -5.71 -1.489
    Net Change in Cash 286.429 290.034 247.91 119.817 -100.613
    Cash Taxes Paid 94.681
    Cash Interest Paid 270.671
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.597 6142541 124439 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 8.3875 5368413 -14950 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.6399 2329692 24635 2023-03-31 LOW
    LSV Asset Management Investment Advisor 3.6222 2318403 262509 2023-03-31 LOW
    JP Morgan Asset Management Investment Advisor 2.9841 1909975 -517529 2023-03-31 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.8997 1855940 -61950 2023-03-31 LOW
    Polaris Capital Management, LLC Investment Advisor 2.0434 1307860 54500 2023-03-31 LOW
    Franklin Advisers, Inc. Investment Advisor/Hedge Fund 2.0082 1285362 12863 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 1.9602 1254609 -35406 2023-03-31 HIGH
    Deep Track Capital LP Hedge Fund 1.8749 1200000 326447 2023-03-31 HIGH
    Millennium Management LLC Hedge Fund 1.868 1195581 719435 2023-03-31 HIGH
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.8257 1168505 358107 2023-03-31 LOW
    Mulligan (Seamus C) Individual Investor 1.8159 1162239 4185 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.4902 953781 17166 2023-03-31 LOW
    Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 1.4795 946960 0 2023-04-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 1.4197 908653 -196782 2023-03-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.3124 840003 2441 2023-03-31 LOW
    Samlyn Capital, LLC Hedge Fund 1.2321 788625 166789 2023-03-31 HIGH
    Janus Henderson Investors Investment Advisor/Hedge Fund 1.0671 682973 -413870 2023-03-31 LOW
    Avidity Partners Management LP Hedge Fund 1.0591 677900 -49641 2023-03-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Pharmaceuticals (NEC)

    Fifth Fl
    Waterloo Exchange
    DUBLIN
    DUBLIN 4
    IE

    Income Statement

    • Annual
    • Quarterly

    People also watch

    XRP/USD

    0.53 Price
    -0.620% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00393

    US100

    14,475.10 Price
    -0.160% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    Oil - Crude

    71.10 Price
    -0.130% 1D Chg, %
    Biaya inap posisi Long -0.0153%
    Biaya inap posisi short -0.0066%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Gold

    1,965.58 Price
    -0.030% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0103%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda